Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Long-Term Deferred Tax (2017 - 2026)

Organogenesis Holdings has reported Long-Term Deferred Tax over the past 9 years, most recently at $30.0 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax fell 24.07% year-over-year to $30.0 million; the TTM value through Dec 2025 reached $30.0 million, down 24.07%, while the annual FY2025 figure was $30.0 million, 24.07% down from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $30.0 million at Organogenesis Holdings, down from $45.6 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $45.6 million in Q3 2025 and troughed at $18000.0 in Q1 2021.
  • A 5-year average of $28.6 million and a median of $31.0 million in 2021 define the central range for Long-Term Deferred Tax.
  • Biggest five-year swings in Long-Term Deferred Tax: skyrocketed 177644.44% in 2021 and later dropped 24.07% in 2025.
  • Year by year, Long-Term Deferred Tax stood at $32.0 million in 2021, then dropped by 6.19% to $30.0 million in 2022, then dropped by 6.7% to $28.0 million in 2023, then soared by 40.93% to $39.5 million in 2024, then dropped by 24.07% to $30.0 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for ORGO at $30.0 million in Q4 2025, $45.6 million in Q3 2025, and $41.8 million in Q2 2025.